MedTrace Logo

Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus

NCT00766480 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

PURPOSE: This clinical trial is studying tissue samples in predicting how well chemotherapy and radiation therapy will kill cancer cells in patients with squamous cell carcinoma of the esophagus.

Conditions

  • Esophageal Cancer

Interventions

DRUG

cisplatin

Given IV

DRUG

fluorouracil

Given IV

RADIATION

radiation therapy

Patients undergo radiotherapy

Sponsors & Collaborators

  • University of Toyama

    lead OTHER

Principal Investigators

  • Yutaka Shimada, MD, PhD · University of Toyama

Study Design

Purpose
TREATMENT
Masking
NONE

Eligibility

Min Age
20 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2010-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00766480 on ClinicalTrials.gov